22 completed, 4 terminated, 2 active not recruiting, 1 not yet recruiting. 30 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 30 | Completed 22, Terminated 4, Active not recruiting 2, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Nicotine: new trials by email Literature Review of Nicotine trials Research Report on Nicotine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| iCanQuit Smoking Cessation Among Hispanic Adults iCanQuit Smartphone App Smoking Cessation Program, Nicotine Gum, Nicotine Patch - Cigarette Smoking-Related Carcinoma | Phase 3 | Not yet recruiting | Fred Hutchinson Cancer Center | 854 | 2026-12-01 | 2026-10-29 |
| Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction | Phase 3 | Completed | Rose Research Center, LLC | 150 | 2024-08-29 | 2026-02-06 |
| Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRT Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction | Phase 3 | Terminated | Rose Research Center, LLC | 4 | 2023-12-27 | 2025-03-30 |
| Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts Nicoderm CQ 21Mg/24Hr Transdermal System - Tobacco Use Cessation | Phase 2 / Phase 3 | Completed | Brown University | 49 | 2021-09-01 | 2025-04-06 |
| Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients Nicotine 7 mg/ 24h Transdermal Patch - 24 Hour, Placebo of NICOTINE Transdermal patch - SARS-COV2 | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 32 | 2020-12-09 | 2022-02-11 |
| Optimizing Tobacco Use Treatment for PLWHA Varenicline, Nicotine patch, Standard treatment - HIV/AIDS, Nicotine Dependence | Phase 3 | Active not recruiting | Abramson Cancer Center at Penn Medicine | 340 | 2020-02-17 | 2026-09-04 |
| Individualizing Pharmacotherapy for African American Smokers Nicotine patch, Varenicline Tartrate, Bupropion - Smoking Cessation | Phase 3 | Completed | University of Kansas Medical Center | 392 | 2019-05-01 | 2023-04-03 |
| Vaping THC From Electronic Cigarettes Nicotine, Cannabis, PAX Loose Leaf Vaporizer - Marijuana Dependence | Phase 3 | Completed | University of California, San Francisco | 8 | 2019-03-20 | 2023-06-29 |
| Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation. Electronic cigarette without nicotine (ECwN) plus active varenicline tablets, Electronic cigarette without nicotine (ECwoN) plus placebo tablets of varenicline, Electronic cigarette with nicotine (ECwN) plus placebo tablets of varenicline - Smoking Cessation, Smoking, Cigarette | Phase 3 | Active not recruiting | Assistance Publique - Hôpitaux de Paris | 650 | 2018-10-17 | 2025-12-29 |
| Effects of Exercise and Nicotine on Cognition in Smokers Nicotine, Moderate Intensity Exercise - Smoking Cessation | Phase 3 | Completed | Western University, Canada | 34 | 2017-05-01 | 2024-05-03 |
| The Use of Nicotine Patches Together With E-cigarettes (With and Without Nicotine) for Smoking Cessation Nicotine patch, e-cigarette, Nicotine - Smoking Cessation | Phase 3 | Completed | University of Auckland, New Zealand | 1124 | 2016-03-01 | 2021-08-19 |
| Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement Nicotine patch, Nicotine mouthspray - Tobacco Use Disorder, Nicotine Dependence | Phase 2 / Phase 3 | Terminated | Centre for Addiction and Mental Health | 18 | 2015-07-01 | 2018-07-19 |
| The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers Nicotine Replacement Therapy (NRT), Varenicline, HIV Tailored Quit Smoking Counseling - HIV, Smoking Cessation | Phase 3 | Unknown | Ottawa Hospital Research Institute | 256 | 2014-01-01 | 2015-12-14 |
| CPT and Smoking Cessation Cognitive Processing Therapy (CPT), Bupropion, nicotine replacement therapy (NRT) - Stress Disorders, Post-Traumatic, Smoking | Phase 2 / Phase 3 | Completed | VA Office of Research and Development | 69 | 2013-12-11 | 2018-09-11 |
| Nicotine Mouth Film for Craving Relief. Nicotine - Smoking Cessation | Phase 3 | Completed | GlaxoSmithKline | 320 | 2012-09-01 | 2014-01-30 |
| A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline Telephone counseling, Nicotine patches, Incentive - Smoking Cessation | Phase 3 | Completed | University of California, San Diego | 3816 | 2012-06-01 | 2020-02-13 |
| Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation Varenicline, Bupropion, Nicotine patches - Nicotine Dependence | Phase 3 | Completed | Duke University | 282 | 2011-07-01 | 2017-11-14 |
| Concurrent Bupropion / Varenicline for Smoking Cessation Varenicline, Bupropion, Nicotine patches - Nicotine Dependence | Phase 3 | Completed | Duke University | 702 | 2011-03-01 | 2014-08-06 |
| Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking Placebo, Nicotine - Tobacco Dependence | Phase 3 | Terminated | McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. | 257 | 2011-03-01 | 2012-04-23 |
| Pharmacogenetics of Nicotine Addiction Treatment Varenicline, Placebo, Transdermal Nicotine - Nicotine Addiction | Phase 3 | Completed | University of Pennsylvania | 1246 | 2010-12-01 | 2016-03-03 |
Showing 20 of 30. Sign in to see all of them.
Smoking Cessation (20) · Tobacco Use Disorder (11) · Smoking (8) · Cigarette Smoking (4) · Tobacco Use Cessation (4) · Vaping (3) · Carcinoma, Non-Small-Cell Lung (2) · Harm Reduction (2) · Lung Neoplasms (2) · Acquired Immunodeficiency Syndrome (1) · COVID-19 (1) · Marijuana Abuse (1) · Motor Activity (1) · Small Cell Lung Carcinoma (1) · Stress Disorders, Post-Traumatic (1)
University of California, San Diego (3) · Assistance Publique - Hôpitaux de Paris (2) · Duke University (2) · GlaxoSmithKline (2) · Rose Research Center, LLC (2) · Abramson Cancer Center at Penn Medicine (1) · Alliance for Clinical Trials in Oncology (1) · Brown University (1) · Centre for Addiction and Mental Health (1) · Fred Hutchinson Cancer Center (1) · McNeil AB (1) · McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. (1) · National Institute on Drug Abuse (NIDA) (1) · Ottawa Hospital Research Institute (1) · SWOG Cancer Research Network (1)
United States (22) · Canada (5) · France (2) · Czechia (1) · New Zealand (1) · Puerto Rico (1)
Shu-Hong Zhu, Ph.D. (3) · Caryn Lerman, PhD (1) · Cheryl A Oncken, MD (1) · Daniel Qi, MD (1) · Elisabeth Kruse, PhD (1) · Ellen R. Gritz, PhD (1) · Eric A Dedert, PhD (1) · F. Joseph McClernon, Ph.D. (1) · Harry Prapavessis, PhD (1) · James Stevenson, MD (1) · Jed E Rose, Ph.D. (1) · Jonathan Bricker, PhD (1) · Karen Cropsey, Ph.D. (1) · Laura MacPherson, PhD (1)
PMID 34611902, PMID 37142273, PMID 24057996, PMID 24934962, PMID 25012994, PMID 25588294, PMID 25732567, PMID 29986268, PMID 30454668, PMID 30614717, PMID 30664539, PMID 30946162, PMID 31129603, PMID 31502736, PMID 31515173, PMID 33300144, PMID 33713409, PMID 35639828, PMID 36387983, PMID 36789481, PMID 37230961, PMID 37338906, PMID 38369951, PMID 39868569, PMID 39976595, PMID 40174410, PMID 40358028
P50DA027840 (2), 2017 (1), K24AA013736 (1), M01RR006192 (1), R01CA243914 (1), R01CA298383 (1), R01DA039264 (1), R01DA046576 (1), R21CA261233 (1), R21DA029445 (1), U01DA020830 (1)